This page contains brief information about luspatercept-aamt and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Luspatercept-aamt is approved to treat:
- Anemia caused by certain types of myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. It is used in adults who need regular red blood cell transfusions and whose anemia did not respond to or cannot be treated with an erythropoiesis-stimulating agent.
Luspatercept-aamt is also being studied in the treatment of other conditions.
More About Luspatercept-aamt
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Luspatercept-aamt - Check for trials from NCI's list of cancer clinical trials now accepting patients.